Guangzhou Improve Med Instrument (300030) — Net Asset Quality Index
Guangzhou Improve Med Instrument (300030) has a Net Asset Quality Index of 66.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.02 Billion minus total liabilities of CN¥346.01 Million yields net assets of CN¥677.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 300030 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Guangzhou Improve Med Instrument Net Asset Quality Index Over Time (2006–2025)
This chart shows how Guangzhou Improve Med Instrument's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 66.2%, representing net assets of CN¥677.10 Million against total assets of CN¥1.02 Billion CNY. Explore cash efficiency ratio of Guangzhou Improve Med Instrument to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Guangzhou Improve Med Instrument (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Guangzhou Improve Med Instrument from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Guangzhou Improve Med Instrument (300030) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 63.8% | CN¥655.10 Million | CN¥1.03 Billion | CN¥371.82 Million | ▲ +12.0 pp |
| 2024 | 51.8% | CN¥643.86 Million | CN¥1.24 Billion | CN¥600.28 Million | ▼ -1.7 pp |
| 2023 | 53.5% | CN¥762.33 Million | CN¥1.43 Billion | CN¥663.63 Million | ▲ +0.8 pp |
| 2022 | 52.7% | CN¥820.61 Million | CN¥1.56 Billion | CN¥737.57 Million | ▼ -3.8 pp |
| 2021 | 56.5% | CN¥1.03 Billion | CN¥1.83 Billion | CN¥794.63 Million | ▼ -1.0 pp |
| 2020 | 57.5% | CN¥1.00 Billion | CN¥1.74 Billion | CN¥741.94 Million | ▲ +1.8 pp |
| 2019 | 55.6% | CN¥838.26 Million | CN¥1.51 Billion | CN¥668.54 Million | ▲ +1.7 pp |
| 2018 | 54.0% | CN¥815.47 Million | CN¥1.51 Billion | CN¥695.67 Million | ▼ -1.2 pp |
| 2017 | 55.2% | CN¥963.72 Million | CN¥1.75 Billion | CN¥782.15 Million | ▼ -9.7 pp |
| 2016 | 64.9% | CN¥954.18 Million | CN¥1.47 Billion | CN¥515.70 Million | ▲ +0.3 pp |
| 2015 | 64.6% | CN¥930.46 Million | CN¥1.44 Billion | CN¥508.88 Million | ▼ -12.1 pp |
| 2014 | 76.7% | CN¥782.00 Million | CN¥1.02 Billion | CN¥237.33 Million | ▼ -10.8 pp |
| 2013 | 87.5% | CN¥772.70 Million | CN¥883.08 Million | CN¥110.38 Million | ▼ -2.2 pp |
| 2012 | 89.7% | CN¥687.93 Million | CN¥766.53 Million | CN¥78.60 Million | ▼ -0.7 pp |
| 2011 | 90.4% | CN¥648.25 Million | CN¥716.72 Million | CN¥68.47 Million | ▼ -0.5 pp |
| 2010 | 91.0% | CN¥592.55 Million | CN¥651.24 Million | CN¥58.69 Million | ▲ +5.3 pp |
| 2009 | 85.7% | CN¥563.53 Million | CN¥657.84 Million | CN¥94.31 Million | ▲ +30.1 pp |
| 2008 | 55.6% | CN¥78.73 Million | CN¥141.69 Million | CN¥62.96 Million | ▼ -23.3 pp |
| 2007 | 78.9% | CN¥58.27 Million | CN¥73.88 Million | CN¥15.61 Million | ▲ +30.5 pp |
| 2006 | 48.4% | CN¥19.33 Million | CN¥39.95 Million | CN¥20.62 Million | — |